EVOLUTIONARY GENOMICS, INC.
EVOLUTIONARY GENOMICS, INC. (FNAM): 12 pipeline candidates · ~10 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
9.8 months
D/E -0.70 · 0% dilution
Lead: Approved
12 candidates
N/A
N/A
A transparent, data-derived signal for EVOLUTIONARY GENOMICS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1K
Cash
$577K
Quarterly Burn
$188K
Runway
9.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (12 candidates)
| Drug | Phase |
|---|---|
| banana genes | Preclinical |
| banana project | Preclinical |
| banana project genes | Preclinical |
| cyklx | Approved |
| eg19 | Preclinical |
| eg261 | Preclinical |
| fusr1 | Preclinical |
| soybean genes | Preclinical |
| soybean project | Preclinical |
| soybean project genes | Preclinical |
Showing 10 of 12 candidates. Sign up for full pipeline.
Frequently asked questions
How many drug candidates are in EVOLUTIONARY GENOMICS, INC.'s pipeline?
EVOLUTIONARY GENOMICS, INC. (FNAM) has 12 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is EVOLUTIONARY GENOMICS, INC.'s lead drug candidate?
EVOLUTIONARY GENOMICS, INC.'s most advanced tracked candidate is banana genes (Preclinical) for Improvement of banana crop traits.
What is EVOLUTIONARY GENOMICS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, EVOLUTIONARY GENOMICS, INC. has approximately 9.8 months of cash runway.
What is EVOLUTIONARY GENOMICS, INC.'s market capitalization?
EVOLUTIONARY GENOMICS, INC.'s market capitalization is approximately $1K.
Who is the CEO of EVOLUTIONARY GENOMICS, INC.?
Mr. Steve B. Warnecke is the chief executive officer of EVOLUTIONARY GENOMICS, INC. (FNAM).
Get the full picture on EVOLUTIONARY GENOMICS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.